Researchers of the UMET achieve a patent that benefits cancer patients.

Two professors from the School of Environmental Affairs of the Metropolitan University (UMET) discovered biomarkers that identify cancer cells with little oxygenation. This discovery was certified by the United States Patent and Trademark Office (USPTO) and will benefit in the diagnosis and treatment of cancer patients.

For the full article, please refer to the spanish version of this site.